Literature DB >> 29077937

PICKLES: the database of pooled in-vitro CRISPR knockout library essentiality screens.

Walter F Lenoir1,2, Tassica L Lim1, Traver Hart1.   

Abstract

The adaptation of CRISPR/Cas9 systems for pooled library genetic knockout screens in mammalian cells has substantially advanced the state of the art in human functional genomics. Screening panels of cell lines for genes whose knockout imposes a significant fitness defect has dramatically expanded our catalog of high-confidence essential genes, and has already proven useful in identifying tumor-specific essential genes for the development of targeted therapies. However, nonexperts currently lack an easy to use way to access this data and to identify whether their genes of interest are essential across different genetic backgrounds. The volume of screening data is expected to grow massively, making the problem more intractable. Here we describe PICKLES, the database of Pooled In vitro CRISPR Knockout Library Essentiality Screens, where end users can display and download raw or normalized essentiality profiles for more that 18 000 protein-coding genes across more than 50 cell lines. An additional data set with 15,000 genes targeted by pooled library shRNA in over 100 cell lines is also included. Researchers can see at a glance the relative fitness defect and tissue specificity of their genes of interest, generate and save figures locally, and download all raw data. The database is available at http://pickles.hart-lab.org.
© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29077937      PMCID: PMC5753353          DOI: 10.1093/nar/gkx993

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


INTRODUCTION

The ability to knock out a gene and observe the resulting phenotype has been a foundational tool for functional genomics for decades. The yeast deletion library has been extensively studied, and recently a near-complete catalog of fitness defects of all pairwise deletions of yeast genes was published. The tractability of yeast genetics made Saccharomyces cerevisiae a powerful model system. The discovery of RNA interference and its adaptation to RNA-guided transcript knockdown brought large-scale genetic screens to higher eukaryotes (1,2) but imprecise targeting, low penetrance, and off-target effects (3–5) led to a loss of confidence in this method for large-scale screens (6). Recently, the application of CRISPR/Cas9 technology to generate double strand breaks in target DNA, whose repair by nonhomologous end joining frequently results in indels, has been exploited to knock out protein coding genes in a variety of model systems by targeted introduction of frameshifts or other deleterious mutations (7,8). Genome-scale CRISPR libraries have been adapted to a variety of screening goals, including knockout libraries for loss of function screens for protein coding genes (9) (10) and noncoding RNA (11,12). The most commonly used CRISPR-associated endonuclease, SpCas9, has been modified to disable its endonuclease activity, facilitating protein fusion with domains for transcriptional activation (13,14), transcriptional repression (13,15), and chromatin modification (16). Multiplexed guide designs have been engineered to enable pairwise gene perturbation screens to detect synthetic lethal genetic interactions (17) and to remove precisely targeted segments of DNA (12). Despite this breadth of available technologies, the most common application of pooled CRISPR libraries is to screen protein coding genes for knockout fitness defects in cancer and other human cell lines. Pooled library screens in cancer are designed to identify the essential genes specific to tumors of a given tissue of origin or even subtype. Early screens demonstrated the power of this differential essentiality approach (18,19) and demonstrated that genotype-specific vulnerabilities could be identified and targeted (20), while subsequent efforts expanded the scope of the cell lines being screened (21,22), and vastly more data is in the pipeline (23,24) (Meyers et al., bioRxiv, 2017). As this massive screening effort expands, so grows the need for a central repository where researchers and the public can easily interpret the data. Here we present PICKLES, the database of Pooled In vitro CRISPR Knockout Library Essentiality Screens. PICKLES presents a easy to use interface where a user can visualize how the essentiality of a given gene varies across experiments and across tissues/cells probed within an experiment. Raw data from large-scale screening efforts is processed through the BAGEL pipeline (25), which generates a log Bayes Factor that represents the confidence level of whether a gene is essential in a given cell line screen. Both raw and normalized BFs are available for download. The PICKLES database currently contains data from four unique CRISPR knockout libraries applied in screens of over 60 cell lines, performed in at least six labs. It additionally contains data from genome-scale shRNA knockdown screens in over 100 cancer cell lines (26–28). We anticipate expanding this database as additional large scale screening data are made available.

DATA SOURCES AND PREPROCESSING WITH BAGEL

Viral-mediated, pooled library CRISPR screens involve transducing a large population of cells with a pooled library of CRISPR reagents (guide RNAs, or gRNA). Expression of SpCas9 or a related endonuclease, either from prior genetic knock-in or encoded on the same viral backbone as the gRNA, results in gRNA-mediated cleavage and, in most cases, error-prone repair of targeted loci. Successful targeting of a fitness gene results in mutation or indels resulting in frameshift, loss of gene function, and subsequent cell death, arrest, or severe fitness defect, causing cells harboring that gRNA to represent an ever smaller fraction of total transduced cells as generations pass. At an endpoint, typically 8–15 doublings after library transduction, gRNA sequences are amplified from genomic DNA and sequenced and their relative abundance is compared to either a control timepoint immediately after infection or to the original plasmid pool. Guide RNA targeting essential genes will be depleted in the final pool, resulting in a strong negative fold change relative to genes with no fitness defect. Raw read count data from all datasets was acquired and processed with BAGEL (25). BAGEL is a Bayesian classifier trained using gold standard reference sets of essential and nonessential genes. The observed fold changes of gRNA targeting uncharacterized genes are compared to the observed fold change distributions of gRNA targeting genes in the training sets and a log Bayes Factor (BF) is calculated. The BF represents the relative confidence that the gene is essential (i.e. that the observed fold changes were more likely drawn from the essential or nonessential distributions; Figure 1A).
Figure 1.

(A) Density plot of fold changes of gRNA targeting essential (red) or nonessential (blue) genes. (B) Distributions of BAGEL Bayes Factor (BF) scores in Tzelepis AML dataset. Cells are screened under uniform conditions but experimental and biological differences drive variance in results. (C) Quantile normalized BFs of the Tzelepis AML dataset, allowing for direct gene BF comparisons across cell lines.

(A) Density plot of fold changes of gRNA targeting essential (red) or nonessential (blue) genes. (B) Distributions of BAGEL Bayes Factor (BF) scores in Tzelepis AML dataset. Cells are screened under uniform conditions but experimental and biological differences drive variance in results. (C) Quantile normalized BFs of the Tzelepis AML dataset, allowing for direct gene BF comparisons across cell lines. The BF for a given gene in a given screen is a function of the number of gRNA targeting that gene, the number of replicates screened, and the number of doublings at the screen endpoint, as well as other global experimental factors. It is also common for BF distributions to vary considerably even within the same set of experiments/screens conducted in a single lab (Figure 1B). For this reason, we have quantile normalized the BF from each experimental set before generating the display (Figure 1C). Both raw and quantile normalized BF data are available for download from the website. However, across-dataset comparisons are still problematic. The different CRISPR libraries generally have different numbers gRNA per gene, as well as wide variation in gRNA knockout efficiency, and the various screening groups often implement experimental designs that differ in number of replicates and timepoints assayed. The BAGEL pipeline accumulates information from each gRNA in each replicate at each timepoint, leading to highly accurate results within a dataset but strong batch effects between datasets. We therefore display the results from each dataset independently.

shRNA data

In addition to CRISPR data, the PICKLES database also contains a large compendium of pooled library shRNA screen data from (26–28). This data has undergone considerably more thorough preprocessing and filtering, including reducing the number of screens to 112 high quality screens, ensuring minimal representation of shRNA in T0 populations, and normalizing to the number of shRNA targeting each gene in each experiment, in order to yield a robust dataset with minimal false positives. These data processing steps are described in (Hart et al., bioRxiv, 2017). Table 1 shows a complete listing of the data available at time of writing. We note that, in general, CRISPR screens show much greater sensitivity and specificity than shRNA screens (29) and that global analyses such as those presented here are less affected by these QC considerations.
Table 1.

Fitness screens currently available in PICKLES

Screen/libraryData typeNumber of genesNumber of cell lines
shRNAEssentiality Score13 395112
GeCKOQuantile Normalized Bayes Factor15 46633
TKOv1Quantile Normalized Bayes Factor17 23010
Tzelepis/YusaQuantile Normalized Bayes Factor17 9975
WangQuantile Normalized Bayes Factor19 16119

DATABASE INTERFACE AND TUTORIAL

The PICKLES database can be found at pickles.hart-lab.org. The main database display tool is found under the ‘Essentiality Map’ tab. Upon entering a valid gene symbol in the input form, the essentiality profile for that gene will be plotted for each data set where that gene is assayed (30). For each display, the primary y-axis plots the gene BFs (blue dots connected by a line), as well as a dashed line at BF = 3 (dashed blue) representing a low-stringency threshold for gene essentiality (29) (Figure 2). Above the plot is a color-coded bar representing the cancer subtype or tissue of origin for the cell line; the key is to the right of the plot. Figure 2 shows the essentiality plot for the FZD5 receptor, which is specifically essential in RNF43-mutant pancreatic ductal adenocarcinoma (PDAC) cells (20). As with all essentiality plots, the figure can be saved locally in png format and the data can be downloaded in a tab-delimited text file.
Figure 2.

BFs of FZD5 in the TKOv1 library dataset. Dashed blue line indicates a threshold for gene essentiality (BF = 3). The tissue key displays the cell line tissue/tumor subtype of origin. The FZD5 receptor is essential in PDAC cells (orange), with all PDAC Bayes Factors falling well above the indicated threshold.

BFs of FZD5 in the TKOv1 library dataset. Dashed blue line indicates a threshold for gene essentiality (BF = 3). The tissue key displays the cell line tissue/tumor subtype of origin. The FZD5 receptor is essential in PDAC cells (orange), with all PDAC Bayes Factors falling well above the indicated threshold. Where available, the target gene expression level is displayed on the same graph. For example, Figure 3A shows the essentiality plot for KRAS in the Project Achilles screens (22), and demonstrates the tissue-specific dependence on KRAS of PDAC and select lung cancer cell lines. Expression level of KRAS drawn from CCLE microarray data is plotted for each cell line in red (right Y axis). In this case, no obvious correlation between expression and essentiality exists. In contrast, breast cancer oncogene FOXA1 (Figure 3B) shows high essentiality and high expression only in HER2+ and luminal breast cancer cell lines.
Figure 3.

(A) BFs of KRAS in the Achilles library dataset (blue), with gene expression data (red). Pancreatic (tissue key; orange) and specific lung (tissue key; cyan) cancer cell lines have high BFs consistent with KRAS dependence in KRAS-mutant cancers. (B) BFs of FOXA1 using the shRNA library dataset. Both gene expression (red) and BFs (blue) are high in luminal and HER2 breast cancer cell lines compared to basal breast, ovarian, pancreatic and colon cancer cell lines.

(A) BFs of KRAS in the Achilles library dataset (blue), with gene expression data (red). Pancreatic (tissue key; orange) and specific lung (tissue key; cyan) cancer cell lines have high BFs consistent with KRAS dependence in KRAS-mutant cancers. (B) BFs of FOXA1 using the shRNA library dataset. Both gene expression (red) and BFs (blue) are high in luminal and HER2 breast cancer cell lines compared to basal breast, ovarian, pancreatic and colon cancer cell lines. Other tabs on the top navigation bar provide links to standard resources. The statistics tab shows summary statistics of the database; at time of writing, these data are summarized in Table 1. Raw data and processed (quantile normalized) data for all screens can be downloaded from the Documents tab, as well as links to the published studies from which these data are derived.

IMPLEMENTATION AND FUTURE DIRECTIONS

The data display is currently implemented exclusively in javascript, using the charts.js library for display. A sqlite database containing all gene essentiality and gene expression data resides on the web server and is queried through a custom python web service. The browser-based javascript modifies the view in response to user selection of options and downloads additional data via http request when the user searches for a new gene. Currently statistical tests are pre-calculated for the existing data and are loaded as static metadata.

CONCLUSIONS

We present PICKLES, the database of Pooled In vitro CRISPR Knockout Library Essentiality Screens, where researchers can explore the gene essentiality profiles of their favorite genes across a large set of CRISPR knockout and shRNA knockdown fitness screens, mostly in cancer cell lines. Raw data from five major data sets of genome-scale screens, for a total of over sixty CRISPR-screened cell lines and over one hundred shRNA-screened cell lines, was acquired and processed with the BAGEL algorithm, resulting in a consistent set of essentiality scores. An easy to use interface allows users to visualize how gene-specific essentiality varies across tissue types and, in many cases, the relationship with gene expression levels in the same cells. We anticipate that this database will grow rapidly as hundreds of screens are known to be in the pipeline in screening labs around the world, and we envision that the PICKLES database will be a broadly useful tool for mining this important resource.
  30 in total

1.  Off-target effects associated with long dsRNAs in Drosophila RNAi screens.

Authors:  Jason Moffat; Jan H Reiling; David M Sabatini
Journal:  Trends Pharmacol Sci       Date:  2007-03-09       Impact factor: 14.819

2.  Essential gene profiles in breast, pancreatic, and ovarian cancer cells.

Authors:  Richard Marcotte; Kevin R Brown; Fernando Suarez; Azin Sayad; Konstantina Karamboulas; Paul M Krzyzanowski; Fabrice Sircoulomb; Mauricio Medrano; Yaroslav Fedyshyn; Judice L Y Koh; Dewald van Dyk; Bodhana Fedyshyn; Marianna Luhova; Glauber C Brito; Franco J Vizeacoumar; Frederick S Vizeacoumar; Alessandro Datti; Dahlia Kasimer; Alla Buzina; Patricia Mero; Christine Misquitta; Josee Normand; Maliha Haider; Troy Ketela; Jeffrey L Wrana; Robert Rottapel; Benjamin G Neel; Jason Moffat
Journal:  Cancer Discov       Date:  2011-12-29       Impact factor: 39.397

3.  Project DRIVE: A Compendium of Cancer Dependencies and Synthetic Lethal Relationships Uncovered by Large-Scale, Deep RNAi Screening.

Authors:  E Robert McDonald; Antoine de Weck; Michael R Schlabach; Eric Billy; Konstantinos J Mavrakis; Gregory R Hoffman; Dhiren Belur; Deborah Castelletti; Elizabeth Frias; Kalyani Gampa; Javad Golji; Iris Kao; Li Li; Philippe Megel; Thomas A Perkins; Nadire Ramadan; David A Ruddy; Serena J Silver; Sosathya Sovath; Mark Stump; Odile Weber; Roland Widmer; Jianjun Yu; Kristine Yu; Yingzi Yue; Dorothee Abramowski; Elizabeth Ackley; Rosemary Barrett; Joel Berger; Julie L Bernard; Rebecca Billig; Saskia M Brachmann; Frank Buxton; Roger Caothien; Justina X Caushi; Franklin S Chung; Marta Cortés-Cros; Rosalie S deBeaumont; Clara Delaunay; Aurore Desplat; William Duong; Donald A Dwoske; Richard S Eldridge; Ali Farsidjani; Fei Feng; JiaJia Feng; Daisy Flemming; William Forrester; Giorgio G Galli; Zhenhai Gao; François Gauter; Veronica Gibaja; Kristy Haas; Marc Hattenberger; Tami Hood; Kristen E Hurov; Zainab Jagani; Mathias Jenal; Jennifer A Johnson; Michael D Jones; Avnish Kapoor; Joshua Korn; Jilin Liu; Qiumei Liu; Shumei Liu; Yue Liu; Alice T Loo; Kaitlin J Macchi; Typhaine Martin; Gregory McAllister; Amandine Meyer; Sandra Mollé; Raymond A Pagliarini; Tanushree Phadke; Brian Repko; Tanja Schouwey; Frances Shanahan; Qiong Shen; Christelle Stamm; Christine Stephan; Volker M Stucke; Ralph Tiedt; Malini Varadarajan; Kavitha Venkatesan; Alberto C Vitari; Marco Wallroth; Jan Weiler; Jing Zhang; Craig Mickanin; Vic E Myer; Jeffery A Porter; Albert Lai; Hans Bitter; Emma Lees; Nicholas Keen; Audrey Kauffmann; Frank Stegmeier; Francesco Hofmann; Tobias Schmelzle; William R Sellers
Journal:  Cell       Date:  2017-07-27       Impact factor: 41.582

4.  Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer.

Authors:  Mauricio Medrano; Laudine Communal; Kevin R Brown; Marcin Iwanicki; Josee Normand; Joshua Paterson; Fabrice Sircoulomb; Paul Krzyzanowski; Marian Novak; Sasha A Doodnauth; Fernando Suarez Saiz; Jane Cullis; Rima Al-Awar; Benjamin G Neel; John McPherson; Ronny Drapkin; Laurie Ailles; Anne-Marie Mes-Massons; Robert Rottapel
Journal:  Cell Rep       Date:  2017-03-07       Impact factor: 9.423

5.  Genetic screens in human cells using the CRISPR-Cas9 system.

Authors:  Tim Wang; Jenny J Wei; David M Sabatini; Eric S Lander
Journal:  Science       Date:  2013-12-12       Impact factor: 47.728

6.  Full-genome RNAi profiling of early embryogenesis in Caenorhabditis elegans.

Authors:  B Sönnichsen; L B Koski; A Walsh; P Marschall; B Neumann; M Brehm; A-M Alleaume; J Artelt; P Bettencourt; E Cassin; M Hewitson; C Holz; M Khan; S Lazik; C Martin; B Nitzsche; M Ruer; J Stamford; M Winzi; R Heinkel; M Röder; J Finell; H Häntsch; S J M Jones; M Jones; F Piano; K C Gunsalus; K Oegema; P Gönczy; A Coulson; A A Hyman; C J Echeverri
Journal:  Nature       Date:  2005-03-24       Impact factor: 49.962

7.  Genetic interaction mapping in mammalian cells using CRISPR interference.

Authors:  Dan Du; Assen Roguev; David E Gordon; Meng Chen; Si-Han Chen; Michael Shales; John Paul Shen; Trey Ideker; Prashant Mali; Lei S Qi; Nevan J Krogan
Journal:  Nat Methods       Date:  2017-05-08       Impact factor: 28.547

8.  International System for Human Gene Nomenclature (1979) ISGN (1979).

Authors:  T B Shows; C A Alper; D Bootsma; M Dorf; T Douglas; T Huisman; S Kit; H P Klinger; C Kozak; P A Lalley; D Lindsley; P J McAlpine; J K McDougall; P Meera Khan; M Meisler; N E Morton; J M Opitz; C W Partridge; R Payne; T H Roderick; P Rubinstein; F H Ruddle; M Shaw; J W Spranger; K Weiss
Journal:  Birth Defects Orig Artic Ser       Date:  1980

9.  Gene Essentiality Profiling Reveals Gene Networks and Synthetic Lethal Interactions with Oncogenic Ras.

Authors:  Tim Wang; Haiyan Yu; Nicholas W Hughes; Bingxu Liu; Arek Kendirli; Klara Klein; Walter W Chen; Eric S Lander; David M Sabatini
Journal:  Cell       Date:  2017-02-02       Impact factor: 41.582

10.  Genome-wide CRISPR screens reveal a Wnt-FZD5 signaling circuit as a druggable vulnerability of RNF43-mutant pancreatic tumors.

Authors:  Zachary Steinhart; Zvezdan Pavlovic; Megha Chandrashekhar; Traver Hart; Xiaowei Wang; Xiaoyu Zhang; Mélanie Robitaille; Kevin R Brown; Sridevi Jaksani; René Overmeer; Sylvia F Boj; Jarrett Adams; James Pan; Hans Clevers; Sachdev Sidhu; Jason Moffat; Stéphane Angers
Journal:  Nat Med       Date:  2016-11-21       Impact factor: 53.440

View more
  37 in total

1.  In Vivo Genome-Wide Pooled RNAi Screens in Cancer Cells to Identify Determinants of Chemotherapy/Drug Response.

Authors:  Margaret L Dahn; Paola Marcato
Journal:  Methods Mol Biol       Date:  2021

2.  Identification of Essential Genes Using Sequential CRISPR and siRNA Screens.

Authors:  Luke DeHart; Oliver P Yockey; Jesse Bakke
Journal:  Methods Mol Biol       Date:  2022

Review 3.  Synthetic Vulnerabilities in the KRAS Pathway.

Authors:  Marta Roman; Elizabeth Hwang; E Alejandro Sweet-Cordero
Journal:  Cancers (Basel)       Date:  2022-06-08       Impact factor: 6.575

4.  KRASG12C inhibition produces a driver-limited state revealing collateral dependencies.

Authors:  Kevin Lou; Veronica Steri; Alex Y Ge; Y Christina Hwang; Christopher H Yogodzinski; Arielle R Shkedi; Alex L M Choi; Dominique C Mitchell; Danielle L Swaney; Byron Hann; John D Gordan; Kevan M Shokat; Luke A Gilbert
Journal:  Sci Signal       Date:  2019-05-28       Impact factor: 8.192

Review 5.  Breaking the chains: deubiquitylating enzyme specificity begets function.

Authors:  Michael J Clague; Sylvie Urbé; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2019-06       Impact factor: 94.444

6.  SynLeGG: analysis and visualization of multiomics data for discovery of cancer 'Achilles Heels' and gene function relationships.

Authors:  Mark Wappett; Adam Harris; Alexander L R Lubbock; Ian Lobb; Simon McDade; Ian M Overton
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

7.  DNA polymerase ι compensates for Fanconi anemia pathway deficiency by countering DNA replication stress.

Authors:  Rui Wang; Walter F Lenoir; Chao Wang; Dan Su; Megan McLaughlin; Qianghua Hu; Xi Shen; Yanyan Tian; Naeh Klages-Mundt; Erica Lynn; Richard D Wood; Junjie Chen; Traver Hart; Lei Li
Journal:  Proc Natl Acad Sci U S A       Date:  2020-12-21       Impact factor: 12.779

8.  The 2018 Nucleic Acids Research database issue and the online molecular biology database collection.

Authors:  Daniel J Rigden; Xosé M Fernández
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

Review 9.  Using microRNA Networks to Understand Cancer.

Authors:  Mihnea Dragomir; Ana Carolina P Mafra; Sandra M G Dias; Catalin Vasilescu; George A Calin
Journal:  Int J Mol Sci       Date:  2018-06-26       Impact factor: 5.923

10.  Repression of the Type I Interferon Pathway Underlies MYC- and KRAS-Dependent Evasion of NK and B Cells in Pancreatic Ductal Adenocarcinoma.

Authors:  Nathiya Muthalagu; Tiziana Monteverde; Ximena Raffo-Iraolagoitia; Robert Wiesheu; Declan Whyte; Ann Hedley; Sarah Laing; Björn Kruspig; Rosanna Upstill-Goddard; Robin Shaw; Sarah Neidler; Curtis Rink; Saadia A Karim; Katarina Gyuraszova; Colin Nixon; William Clark; Andrew V Biankin; Leo M Carlin; Seth B Coffelt; Owen J Sansom; Jennifer P Morton; Daniel J Murphy
Journal:  Cancer Discov       Date:  2020-03-21       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.